4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000107
Director sold 10,718 shares at $28.36 ($303,962)
- Director acquired 23,900 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
FOUSE JACQUALYN A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-28 | Exercise or conversion : show line 1 in the form 10b5-1 | +23,900 | 117,684 | D | ||
| 2023-06-30 | Sale : show line 2 in the form 10b5-1 | −10,718 | $28.36 | $303,962 | 106,966 | D |
| Open-market sales · 10,718 sh · avg $28.36 · $303,962 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-28 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −23,900 | 23,900 | D |
Loading xslF345X04/wk-form4_1688155663.xml…